<i>De novo</i> activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation

Abstract

Escape mutations from anti-HBs caused de novo activation of HBV under HBIG prophylaxis after liver transplantation. Early administration of entecavir was effective on de novo activation of HBV with anti-HBs escape mutations.